INDIRECT TREATMENT COMPARISON OF MYALEPTA (METRELEPTIN) COMPARED TO BEST SUPPORTIVE CARE IN LIPODYSTROPHY

被引：0
|
作者：
Shenyan, O. [1 ]
Carr, E. [2 ]
Das, R. [3 ]
O'Rahilly, S. [4 ]
机构：
[1] FIECON Ltd, London, England
[2] Amyrt Pharma, Dublin, Ireland
[3] FIECON Ltd, St Albans, England
[4] Univ Cambridge, Cambridge, England
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRO10
引用
收藏
页码：S199 / S199
页数：1
相关论文
共 50 条
  • [1] Is treatment with oral topotecan plus best supportive care associated with better health status compared to best supportive care alone in small cell lung cancer?
    Chen, Lei
    Antras, Lucia
    Duh, Mei Sheng
    Pickard, Simon
    Cella, David
    Neary, Maureen
    O'Brien, Mary E.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S391 - S392
  • [2] Treatment of locally advanced pancreatic carcinoma in Sweden - A health economic comparison of palliative treatment with best supportive care versus palliative treatment with gemcitabine in combination with best supportive care
    Ragnarson-Tennvall, G
    Wilking, N
    PHARMACOECONOMICS, 1999, 15 (04) : 377 - 384
  • [3] Treatment of locally advanced pancreatic carcinoma in Sweden: A health economic comparison of palliative treatment with best supportive care versus palliative treatment with gemcitabine in combination with best supportive care
    Ragnarson-Tennvall G.
    Wilking N.
    PharmacoEconomics, 1999, 15 (4) : 377 - 384
  • [4] Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer
    Glimelius, B
    Ekstrom, K
    Hoffman, K
    Graf, W
    Sjoden, PO
    Haglund, U
    Svensson, C
    Enander, LK
    Linne, T
    Sellstrom, H
    Heuman, R
    ANNALS OF ONCOLOGY, 1997, 8 (02) : 163 - 168
  • [5] Cost-effectiveness of abobotulinumtoxinA plus best supportive care compared with best supportive care alone for early treatment of adult lower limb spasticity following an acute event
    Moore, Peter
    Danchenko, Natalya
    Weidlich, Diana
    Tijerina, Alejandra Rodarte
    PLOS ONE, 2024, 19 (02):
  • [6] INDIRECT TREATMENT COMPARISONS OF NIVOLUMAB VERSUS REGORAFENIB, CABOZANTINIB AND BEST SUPPORTIVE CARE AFTER TREATMENT WITH SORAFENIB FOR HEPATOCELLULAR CARCINOMA
    Roskell, N.
    Gregory, J.
    Wisniewski, T.
    Thompson, G. J.
    De la Cruz, C.
    VALUE IN HEALTH, 2018, 21 : S17 - S18
  • [7] Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma
    Jassem, Jacek
    Ramlau, Rodryg
    Santoro, Armando
    Schuette, Wolfgang
    Chemaissani, Assad
    Hong, Shengyan
    Blatter, Johannes
    Adachi, Susumu
    Hanauske, Axel
    Manegold, Christian
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) : 1698 - 1704
  • [8] Cost-effectiveness of rimegepant oral lyophilisate compared to best supportive care for the acute treatment of migraine in the UK
    Johnston, Karissa
    Powell, Lauren C.
    Popoff, Evan
    L'Italien, Gil J.
    Pawinski, Robert
    Ahern, Aideen
    Large, Sam
    Tran, Thang
    Jenkins, Aaron
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 627 - 643
  • [9] Cost-effectiveness of rimegepant oral lyophilisate compared to best supportive care for the acute treatment of migraine in the UK
    Johnston, K.
    Powell, L.
    Popoff, E.
    L'Italien, G.
    Pawinski, R.
    Ahern, A.
    Large, S.
    Tran, T.
    Jenkins, A.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [10] COST-EFFECTIVENESS ANALYSIS OF TREATMENT WITH ABOBOTULINUMTOXINA COMPARED TO BEST SUPPORTIVE CARE IN PATIENTS WITH UPPER LIMB SPASTICITY IN SWEDEN
    Forsmark, A.
    Danchenko, N.
    Ertzgaard, P.
    Lundkvist, J.
    Rosengren, L.
    VALUE IN HEALTH, 2018, 21 : S338 - S339
12345